FDA Evaluating Reports Of Adverse Reactions To Diabetes, Diet Drugs
SILVER SPRINGS, Md. — The U.S. Food and Drug Administration said it “is evaluating the need for regulatory action” after receiving reports that diabetes and diet drugs such as Ozempic, Wegovy...To view the full article, register now.
Already a subscriber? Click here to view full article